Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
about
NMDA receptor modulators: an updated patent review (2013-2014)The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Functional assessment of the NMDA receptor variant GluN2A R586K.NMDA receptors control vagal afferent excitability in the nucleus of the solitary tract.Subunit-selective allosteric inhibition of glycine binding to NMDA receptorsTCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive mannerContribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptorsInfluence of GluN2 subunit identity on NMDA receptor function.GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.NMDA Receptors in the Central Nervous System.Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers.Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons.Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties.
P2860
Q26997407-7F75F5CE-FE90-477D-9DD6-124D23AF6705Q30486732-888B4F8E-F7AF-49A7-8149-07936132BABBQ33609970-43151BC1-AF36-4AAE-8170-22B6D48832E9Q35088210-8E450FED-6F11-48DF-81BC-3202D9537689Q35971484-E0DF1EB1-E3F7-4BC9-A310-281CC939AA2EQ36060938-BFE409AD-748C-470E-8E75-840E756F006CQ36776735-E07C6A73-EC44-4CA9-ADCF-CDC415DB547BQ38078685-E54CAFD4-4FD1-457F-AD33-637BAC567CFAQ39393906-DBAB8025-95ED-4758-8986-E24E197B821CQ48029905-C1517E1A-A6B7-47FF-B7C4-93930FDAC30AQ48225409-1D93F754-746E-42C9-911D-658F64C674C3Q50344665-D7A28621-0C53-40C4-B237-E56456EE5BEBQ50418409-4B7D9717-8A65-4CBB-A02F-68081EA2E889
P2860
Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Direct pharmacological monitor ...... , glycine-dependent antagonist
@ast
Direct pharmacological monitor ...... , glycine-dependent antagonist
@en
type
label
Direct pharmacological monitor ...... , glycine-dependent antagonist
@ast
Direct pharmacological monitor ...... , glycine-dependent antagonist
@en
prefLabel
Direct pharmacological monitor ...... , glycine-dependent antagonist
@ast
Direct pharmacological monitor ...... , glycine-dependent antagonist
@en
P2093
P2860
P1476
Direct pharmacological monitor ...... , glycine-dependent antagonist
@en
P2093
E B Thubron
N H Griffiths
P A Butters
P2860
P304
P356
10.1111/J.1476-5381.2011.01748.X
P407
P577
2012-06-01T00:00:00Z